Andrew E. Sloan
#150,198
Most Influential Person Now
American neurosurgeon and physician-scientist
Andrew E. Sloan's AcademicInfluence.com Rankings
Andrew E. Sloanphilosophy Degrees
Philosophy
#10321
World Rank
#14135
Historical Rank
#1896
USA Rank
Logic
#7219
World Rank
#8907
Historical Rank
#1062
USA Rank
Andrew E. Sloanbiology Degrees
Biology
#14044
World Rank
#17691
Historical Rank
#2781
USA Rank
Neuroscience
#2474
World Rank
#2539
Historical Rank
#296
USA Rank
Download Badge
Philosophy Biology
Andrew E. Sloan's Degrees
- Doctorate Medicine Harvard University
- PhD Neuroscience Stanford University
Why Is Andrew E. Sloan Influential?
(Suggest an Edit or Addition)According to Wikipedia, Andrew Edward Sloan is an American neurosurgeon and physician-scientist. He is the Peter D. Cristal Chair of Neurosurgical Oncology at Case Western Reserve University. In June 2000, Sloan married biostatistician and data scientist Jill S. Barnholtz-Sloan at the Missouri Botanical Garden.
Andrew E. Sloan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The Somatic Genomic Landscape of Glioblastoma (2013) (3693)
- The Immune Landscape of Cancer (2018) (2766)
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. (2015) (2211)
- Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) (1646)
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma (2016) (1474)
- Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) (1360)
- Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. (2004) (1322)
- Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth (2013) (725)
- Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. (2003) (670)
- Periostin Secreted by Glioblastoma Stem Cells Recruits M2 Tumor-associated Macrophages and Promotes Malignant Growth (2014) (651)
- NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. (2012) (650)
- Pathogenic Germline Variants in 10,389 Adult Cancers (2018) (501)
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) (471)
- EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. (2009) (441)
- Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide (2011) (394)
- Brain Tumor Initiating Cells Adapt to Restricted Nutrition through Preferential Glucose Uptake (2013) (381)
- A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo. (2016) (368)
- Acidic stress promotes a glioma stem cell phenotype (2011) (343)
- Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma (2007) (324)
- First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma (2018) (321)
- A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study. (2015) (318)
- Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution (2015) (307)
- Glioma Stem Cell Proliferation and Tumor Growth Are Promoted by Nitric Oxide Synthase-2 (2011) (304)
- Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. (2003) (279)
- Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. (2011) (242)
- Targeting Glioma Stem Cells through Combined BMI1 and EZH2 Inhibition (2017) (240)
- LONGITUDINAL MOLECULAR TRAJECTORIES OF DIFFUSE GLIOMA IN ADULTS (2019) (223)
- Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma. (2020) (213)
- Susceptibility‐weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses (2006) (203)
- Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma: clinical article. (2013) (190)
- Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context (2018) (188)
- N 6 -methyladenine DNA Modification in Glioblastoma (2018) (183)
- Metabolic targeting of lactate efflux by malignant glioma inhibits invasiveness and induces necrosis: an in vivo study. (2011) (180)
- Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial. (2014) (176)
- Stereotactic radiosurgery--an organized neurosurgery-sanctioned definition. (2007) (174)
- Cancer Stem Cell‐Specific Scavenger Receptor CD36 Drives Glioblastoma Progression (2014) (162)
- Silencing of Monocarboxylate Transporters via Small Interfering Ribonucleic Acid Inhibits Glycolysis and Induces Cell Death in Malignant Glioma: An in Vitro Study (2004) (153)
- Laminin alpha 2 enables glioblastoma stem cell growth (2012) (147)
- Diagnosis and treatment of melanoma brain metastasis: a literature review. (2009) (144)
- The Somatic Genomic Landscape of Glioblastoma (2014) (135)
- Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential (2011) (127)
- Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. (2008) (125)
- The role of surgery in the management of patients with diffuse low grade glioma (2015) (124)
- A nomogram for individualized estimation of survival among patients with brain metastasis. (2012) (122)
- MR Fingerprinting of Adult Brain Tumors: Initial Experience (2017) (118)
- Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity. (2012) (115)
- Descriptive epidemiology of pituitary tumors in the United States, 2004-2009. (2014) (112)
- Gliosarcoma with multiple extracranial metastases: case report and review of the literature (2007) (106)
- Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination (2017) (98)
- Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010 (2014) (97)
- An independently validated survival nomogram for lower grade glioma. (2019) (93)
- An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. (2016) (86)
- Glioma Stem Cell Specific Super Enhancer Promotes Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling. (2019) (86)
- Lactate and malignant tumors: A therapeutic target at the end stage of glycolysis (2007) (86)
- Relative survival rates and patterns of diagnosis analyzed by time period for individuals with primary malignant brain tumor, 1973-1997. (2003) (85)
- Molecular Subtypes of Glioblastoma Are Relevant to Lower Grade Glioma (2014) (81)
- Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma (2020) (80)
- Adoptive immunotherapy in patients with recurrent malignant glioma: preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony-stimulating factor and adoptive transfer of anti-CD3-activated lymphocytes. (2000) (80)
- Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Surgery in the Management of Adults With Metastatic Brain Tumors (2019) (78)
- In Vivo Uptake and Metabolism of α-[11C]Methyl-l-Tryptophan in Human Brain Tumors (2006) (75)
- Racial/ethnic differences in survival among elderly patients with a primary glioblastoma (2007) (74)
- METABOLIC REMODELING OF MALIGNANT GLIOMAS FOR ENHANCED SENSITIZATION DURING RADIOTHERAPY: AN IN VITRO STUDY (2006) (72)
- Racial differences in survival after diagnosis with primary malignant brain tumor (2003) (72)
- High-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor. (2014) (70)
- In vitro Drug Response and Molecular Markers Associated with Drug Resistance in Malignant Gliomas (2006) (68)
- Topical Application of Activity-based Probes for Visualization of Brain Tumor Tissue (2012) (67)
- Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme. (2012) (65)
- Characterizing Mutational Heterogeneity in a Glioblastoma Patient with Double Recurrence (2012) (65)
- Proteolytic cleavage of protein tyrosine phosphatase mu regulates glioblastoma cell migration. (2009) (64)
- Gamma knife radiosurgery for renal cell carcinoma brain metastases. (2002) (64)
- Network Signatures of Survival in Glioblastoma Multiforme (2013) (64)
- Cadherin-11, a Marker of the Mesenchymal Phenotype, Regulates Glioblastoma Cell Migration and Survival In Vivo (2012) (64)
- ACR Appropriateness Criteria ® spinal bone metastases. (2012) (63)
- An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825 (2016) (62)
- Relationship of gliomas to the ventricular walls (2009) (61)
- Aptamer identification of brain tumor-initiating cells. (2013) (57)
- Pharmacological Targeting of the Histone Chaperone Complex FACT Preferentially Eliminates Glioblastoma Stem Cells and Prolongs Survival in Preclinical Models. (2016) (57)
- Glioma progression is shaped by genetic evolution and microenvironment interactions (2022) (56)
- PTPmu suppresses glioma cell migration and dispersal. (2009) (55)
- Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma (2019) (55)
- In vivo uptake and metabolism of alpha-[11C]methyl-L-tryptophan in human brain tumors. (2006) (53)
- ACR Appropriateness Criteria Follow-Up of Malignant or Aggressive Musculoskeletal Tumors. (2016) (51)
- Extracranial metastasis of gliobastoma: Three illustrative cases and current review of the molecular pathology and management strategies. (2015) (51)
- Erratum: The somatic genomic landscape of glioblastoma (Cell (2013) 155 (462-477)) (2014) (49)
- Clinical trial participation among patients enrolled in the Glioma Outcomes Project (2002) (49)
- Stereotactic laser ablation as treatment for brain metastases that recur after stereotactic radiosurgery: a multiinstitutional experience. (2016) (48)
- Role of FDG‐PET/MRI, FDG‐PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas (2017) (48)
- Comparative Brain and Central Nervous System Tumor Incidence and Survival between the United States and Taiwan Based on Population-Based Registry (2016) (47)
- Bayesian estimation of multicomponent relaxation parameters in magnetic resonance fingerprinting (2018) (46)
- Whole genome sequence analysis links chromothripsis to EGFR, MDM2, MDM4, and CDK4 amplification in glioblastoma (2015) (45)
- Genome-Wide Methylation Analyses in Glioblastoma Multiforme (2014) (45)
- A Phase III study of radiation therapy (RT) and O6-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001 (2015) (44)
- The Zinc Finger Transcription Factor ZFX Is Required for Maintaining the Tumorigenic Potential of Glioblastoma Stem Cells (2014) (44)
- Plant Virus-Like Particle In Situ Vaccine for Intracranial Glioma Immunotherapy (2019) (43)
- Gamma knife radiosurgery for intracranial metastatic melanoma: a 6-year experience. (2002) (43)
- ACR Appropriateness Criteria® Metastatic Epidural Spinal Cord Compression and Recurrent Spinal Metastasis. (2015) (42)
- Incidence patterns for primary malignant spinal cord gliomas: a Surveillance, Epidemiology, and End Results study. (2011) (39)
- A novel molecular diagnostic of glioblastomas: detection of an extracellular fragment of protein tyrosine phosphatase mu. (2010) (37)
- RNAi Based Approaches to the Treatment of Malignant Glioma (2006) (37)
- Laser Ablation of Abnormal Neurological Tissue Using Robotic Neuroblate System (LAANTERN): Procedural Safety and Hospitalization. (2019) (36)
- Laser interstitial thermal therapy followed by minimal-access transsulcal resection for the treatment of large and difficult to access brain tumors. (2016) (36)
- Pediatric brain tumors in Non-Hispanics, Hispanics, African Americans and Asians: differences in survival after diagnosis (2005) (35)
- Surgical rehearsal platform: potential uses in microsurgery. (2013) (35)
- Endothelial expression of TNF receptor-1 generates a proapoptotic signal inhibited by integrin α6β1 in glioblastoma. (2012) (35)
- Dendritic cell immunotherapy for solid tumors: evaluation of the DCVax® platform in the treatment of glioblastoma multiforme. (2015) (34)
- Stereotactic Laser Ablation as Treatment for Brain Metastases Recurring after Stereotactic Radiosurgery: A Systematic Literature Review. (2019) (32)
- Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN): 12-Month Outcomes and Quality of Life After Brain Tumor Ablation (2020) (32)
- Patterns of Clinical Use of Stereotactic Laser Ablation: Analysis of a Multicenter Prospective Registry. (2018) (32)
- Systematic Comparison of Dendritic Cell-based Immunotherapeutic Strategies for Malignant Gliomas: In Vitro Induction of Cytolytic and Natural Killer-like T Cells (2004) (31)
- Sex is an important prognostic factor for glioblastoma but not for nonglioblastoma. (2019) (31)
- MicroRNA and brain tumors: a cause and a cure? (2007) (31)
- Fluorescent-Guided Surgical Resection of Glioma with Targeted Molecular Imaging Agents: A Literature Review. (2016) (30)
- Systematic review of the diagnosis and management of malignant extradural spine cord compression: The Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group. (2005) (30)
- Targeted radioimmunotherapy: the role of ¹³¹I-chTNT-1/B mAb (Cotara) for treatment of high-grade gliomas. (2012) (29)
- MODIFICATIONS OF THE TRANSORAL APPROACH TO THE CRANIOVERTEBRAL JUNCTION: ANATOMIC STUDY AND CLINICAL CORRELATIONS (2008) (29)
- Texture descriptors to distinguish radiation necrosis from recurrent brain tumors on multi-parametric MRI (2014) (29)
- Extended Transoral Approaches: Surgical Technique and Analysis (2010) (28)
- Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED10 (2018) (28)
- Vascular complications after radiosurgery for meningiomas. (2007) (28)
- Spinal cord and peripheral nerve injury: current management and investigations. (2003) (28)
- Integrated genomic analysis of survival outliers in glioblastoma (2016) (28)
- Magnetic Resonance Fingerprinting to Characterize Childhood and Young Adult Brain Tumors (2019) (27)
- Stereotactic body radiation therapy for spinal metastases. (2010) (27)
- AI-based Prognostic Imaging Biomarkers for Precision Neurooncology: the ReSPOND Consortium. (2020) (26)
- Federated learning enables big data for rare cancer boundary detection (2022) (26)
- Family History of Cancer in Benign Brain Tumor Subtypes Versus Gliomas (2012) (25)
- An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival (2019) (25)
- Radiomic analysis of magnetic resonance fingerprinting in adult brain tumors (2020) (25)
- The role of neuropathology in the management of patients with diffuse low grade glioma (2015) (25)
- Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in Glioblastoma (2020) (25)
- Stereotactic radiosurgery and radiation therapy for spinal tumors (2007) (24)
- Lifetime Occurrence of Brain Metastases Arising from Lung, Breast, and Skin Cancers in the Elderly: A SEER-Medicare Study (2019) (22)
- Laser interstitial thermotherapy (LITT) for the treatment of tumors of the brain and spine: a brief review (2021) (22)
- Convection-enhanced delivery of 131I-chTNT-1/B mAB for treatment of high-grade adult gliomas (2011) (22)
- SATB2 drives glioblastoma growth by recruiting CBP to promote FOXM1 expression in glioma stem cells (2020) (22)
- Methylation markers of malignant potential in meningiomas. (2013) (22)
- Symptomatic neurocutaneous melanosis and Dandy-Walker malformation in an adult. (2009) (21)
- Extra-CNS metastasis from glioblastoma: a rare clinical entity (2015) (21)
- Dendritic cell-based active specific immunotherapy for malignant glioma (2007) (20)
- Single versus multiple session stereotactic body radiotherapy for spinal metastasis: the risk-benefit ratio. (2015) (19)
- Protein tyrosine phosphatase mu regulates glioblastoma cell growth and survival in vivo. (2012) (19)
- Risk of subsequent cancer following a primary CNS tumor (2013) (18)
- Comparison of Ray Tracing and Monte Carlo Calculation Algorithms for Thoracic Spine Lesions Treated With CyberKnife-Based Stereotactic Body Radiation Therapy (2016) (17)
- ACR Appropriateness Criteria® Primary Bone Tumors. (2020) (17)
- Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy in the management of intracranial ependymoma (2006) (17)
- Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer (2014) (17)
- Dendritic Cell-Based Immunotherapy of Malignant Gliomas (2004) (16)
- Laser-Induced Interstitial Thermotherapy of Gliomas. (2018) (15)
- Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas (2019) (15)
- The ratio of HLA-DR and VNN2+ expression on CD14+ myeloid derived suppressor cells can distinguish glioblastoma from radiation necrosis patients (2017) (15)
- Enhanced T Cell Migration to Sites of Microscopic CNS Disease: Complementary Treatments Evaluated by 2‐ and 3‐D Image Analysis (1994) (15)
- pH, Lactate, and Hypoxia: Reciprocity in Regulating High-Affinity Monocarboxylate Transporter Expression in Glioblastoma1 (2017) (14)
- Glioblastoma in the elderly. (2012) (14)
- Multi-institutional noninvasive in vivo characterization of IDH, 1p/19q, and EGFRvIII in glioma using neuro-Cancer Imaging Phenomics Toolkit (neuro-CaPTk) (2020) (13)
- International Differences in Treatment and Clinical Outcomes for High Grade Glioma (2015) (13)
- Radiation Necrosis from Stereotactic Radiosurgery—How Do We Mitigate? (2021) (13)
- Targeting glioma-initiating cells in GBM: ABTC-0904, a randomized phase 0/II study targeting the Sonic Hedgehog-signaling pathway. (2014) (12)
- Brain injury: current management and investigations. (2003) (12)
- The role of emerging therapy in the management of patients with diffuse low grade glioma (2015) (11)
- Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma (2018) (11)
- Iatrogenic immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide: A NABTT CNS Consortium study. (2010) (10)
- A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma. (2020) (10)
- Establishing a process of irradiating small animal brain using a CyberKnife and a microCT scanner. (2014) (10)
- Treatment and surgical factors associated with longer-term glioblastoma survival: a National Cancer Database study (2020) (9)
- Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825 (2021) (9)
- Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases (2019) (9)
- Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments (2021) (9)
- Somatic alterations in brain tumors. (2008) (9)
- Association of cancer center type with treatment patterns and overall survival for patients with sacral and spinal chordomas: an analysis of the National Cancer Database from 2004 to 2015. (2020) (9)
- Morbidity and Mortality after Burrhole Craniostomy versus Craniotomy for Chronic Subdural Hematoma Evacuation: A Single-Center Experience. (2020) (9)
- A novel use of the NeuroBlate SideFire probe for minimally invasive disconnection of a hypothalamic hamartoma in a child with gelastic seizures. (2018) (9)
- Development of a Monte Carlo model for treatment planning dose verification of the Leksell Gamma Knife Perfexion radiosurgery system. (2016) (9)
- Ongoing clinical trials. (2003) (9)
- "In-gel" purified ditags direct synthesis of highly efficient SAGE Libraries (2002) (8)
- Introduction: Laser ablation techniques. (2016) (8)
- A phase II and pharmacodynamic trial of RO4929097 for patients with recurrent/progressive glioblastoma. (2011) (8)
- Metabolic Remodeling Of Malignant Gliomas Forenhanced Sensitization During Radiotherapy: An In Vitro Study. (2006) (7)
- TARGETING GLIOMA INITIATING CELLS IN GBM: ABTC-0904, A RANDOMIZED PHASE 0/II STUDY TARGETING THE SONIC HEDGEHOG-SIGNALING PATHWAY (2014) (7)
- Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies (2020) (7)
- Extended transoral approaches: surgical technique and analysis. (2010) (7)
- A Liquid Biopsy to Assess Brain Tumor Recurrence: Presence of Circulating Mo-MDSC and CD14+ VNN2+ Myeloid Cells as Biomarkers That Distinguish Brain Metastasis From Radiation Necrosis Following Stereotactic Radiosurgery. (2020) (7)
- Guidelines in the management of CNS tumors (2021) (7)
- Human Autologous Dendritic Cell–Glioma Fusions: Feasibility and Capacity to Stimulate T cells with Proliferative and Cytolytic Activity (2003) (6)
- Limited brain metastases: a narrative review. (2021) (6)
- MGMT methylation in newly-diagnosed glioblastoma multiforme (GBM): From the S0001 phase III study of radiation therapy (RT) and O6-benzylguanine, (O6BG) plus BCNU versus RT and BCNU alone for newly diagnosed GBM. (2006) (6)
- Gamma knife radiosurgery in patients with advanced breast cancer undergoing bone marrow transplant. (2002) (6)
- Monteris AXiiiS Stereotactic Miniframe for Intracranial Biopsy: Precision, Feasibility, and Ease of Use (2015) (6)
- Autologous heat shock protein vaccine (HSPPC-96) for patients with recurrent glioblastoma (GBM): Results of a phase II multicenter clinical trial with immunological assessments. (2011) (6)
- An IDH1-mutated primary gliosarcoma: case report. (2017) (6)
- Novel multidisciplinary approaches in the management of metastatic epidural spinal cord compression. (2018) (6)
- Brain tumor biobanking in the precision medicine era: building a high-quality resource for translational research in neuro-oncology. (2017) (6)
- CLIN-ONGOING CLINICAL TRIALS (2012) (5)
- Impact of race on care, readmissions, and survival for patients with glioblastoma: an analysis of the National Cancer Database (2021) (5)
- Disparities in the use of stereotactic radiosurgery for the treatment of lung cancer brain metastases: a SEER-Medicare study (2019) (5)
- 219 Liquid Biopsy Can Distinguish Recurrent Glioblastomas From Pseudoprogression and Radiation Necrosis After Concurrent Radiochemotherapy. (2016) (4)
- A phase I study of MGMT-P140K transfected hematopoetic progenitor cells (HPC) combined with TMZ/O6BG dose escalation for newly diagnosed, MGMT unmethylated glioblastoma: Tolerance and evidence of survival benefit. (2019) (4)
- Early necrosis following concurrent temozolomide and radiotherapy in adult patients with glioblastoma. (2006) (4)
- Heroin inhalation complicated by refractory hydrocephalus: A novel presentation (2015) (4)
- Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors (2022) (4)
- Surgical Rehearsal Platform: Potential Uses in Microsurgery. (2013) (3)
- An Independently Validated Nomogram for Individualized Estimation of Survival Among Patients With Newly Diagnosed Glioblastoma: NRG Oncology/RTOG 0525 and 0825 (2016) (3)
- Development of a Monte Carlo model for treatment planning dose verification of the Leksell Gamma Knife Perfexion radiosurgery system (2016) (3)
- Association of metabolic syndrome with glioblastoma: a retrospective cohort study and review. (2020) (3)
- Proteins inform survival-based differences in patients with glioblastoma (2020) (3)
- Racial/ethnic differences in survival for patients with gliosarcoma: an analysis of the National cancer database (2019) (3)
- Healthy myeloid-derived suppressor cells express the surface ectoenzyme Vanin-2 (VNN2). (2021) (3)
- The Use of 5-ALA in Glioblastoma Resection: Two Cases with Long-Term Progression-Free Survival (2014) (3)
- Survival in Patients with High-Grade Spinal Meningioma: An Analysis of the National Cancer Database. (2019) (3)
- A PTPmu Biomarker is Associated with Increased Survival in Gliomas (2019) (3)
- Modeling the growth dynamics of glioblastoma using magnetic resonance imaging. (2015) (3)
- RTHP-07. TREATMENT OF BRAIN RADIATION NECROSIS WITH HYPERBARIC OXYGEN: REPORT OF 6 CASES (2017) (2)
- Stereotactic radiosurgery for more than four brain metastases. (2014) (2)
- ATCT-28THE MODIFIED ATKINS DIET IN RECURRENT GLIOMA: A RETROSPECTIVE REVIEW (2015) (2)
- Human autologous dendritic cell-glioma fusions: feasibility and capacity to stimulate T cells with proliferative and cytolytic activity (2007) (2)
- Phase I/II study of laser interstitial thermotherapy (LITT) combined with checkpoint inhibitor for recurrent glioblastoma (rGBM). (2018) (2)
- Development and Validation of a Small Animal Immobilizer and Positioning System for the Study of Delivery of Intracranial and Extracranial Radiotherapy Using the Gamma Knife System (2017) (2)
- Radiomics-based identification of peritumoral infiltration in de novo glioblastoma imaging presents targets amenable for potential targeted extended resection: A neurosurgical survey. (2019) (2)
- Novel 3D magnetic resonance fingerprinting radiomics in adult brain tumors: a feasibility study (2022) (2)
- 141 Phase I Trial of Genetically Modified Hematopoietic Progenitor Cells Facilitate Bone Marrow Chemoprotection and Enabling TMZ/O6BG Dose Escalation Resulting in Improved Survival. (2016) (2)
- Differentiation of recurrent spinal ependymoma from postradiation treatment necrosis through multiparametric PET-MR and perfusion MRI. (2017) (2)
- A randomized, double‑blind, controlled phase IIb study of the safety and efficacy of ICT‑107 in newly diagnosed patients with glioblastoma multiforme following resection and chemoradiation. (2012) (2)
- First human application of laser interstitial thermal therapy in GBM using MR Guided AutoLITT system (2009) (2)
- Surgery for glioblastoma multiforme. (2011) (2)
- NRG BN002: Phase I study of checkpoint inhibitors anti-CTLA-4, anti-PD-1, the combination in patients with newly diagnosed glioblastoma. (2018) (2)
- What is the most appropriate clinical target volume for glioblastoma? (2013) (2)
- RNAi-based Approaches to the Treatment of Brain Tumors (2011) (2)
- Ra-052. Computerized Image Analysis Of Texture Descriptors In Multi-parametric Mri To Distinguish Recurrent Glioblastoma Multiforme From Radiation Necrosis (2013) (2)
- Integrin α3β1 promotes vessel formation of glioblastoma-associated endothelial cells through calcium-mediated macropinocytosis and lysosomal exocytosis (2022) (2)
- Abstract P6-16-03: Intrinsic subtypes and MRI patterns in brain metastasis associated with breast cancer (2015) (2)
- In Vivo Tissue Characterization of Focal Nodular Heterotopia Using Magnetic Resonance Fingerprinting (2019) (1)
- Survival analysis of patients with glioblastoma multiforme treated with external radiotherapy followed by gamma knife radiosurgery or permanent iodine-125 implant boost (2001) (1)
- Omics and Prognostic Markers (2010) (1)
- CTNI-49. PHASE I STUDY OF MGMT-P140K TRANSFECTED HEMATOPOETIC PROGENITOR CELLS COMBINED WITH TMZ/O6BG DOSE ESCALATION FOR NEWLY DIAGNOSED, UNMETHYLATED GLIOBLASTOMA: TOLERANCE AND EVIDENCE OF SURVIVAL BENEFIT (2020) (1)
- NIMG-66. AI-BASED PROGNOSTIC IMAGING BIOMARKERS FOR PRECISION NEUROONCOLOGY AND THE RESPOND CONSORTIUM (2020) (1)
- Glioma stem cells activate platelets by plasma-independent thrombin production to promote glioblastoma tumorigenesis (2022) (1)
- 219 Liquid Biopsy Can Distinguish Recurrent Glioblastomas From Pseudoprogression and Radiation Necrosis After Concurrent Radiochemotherapy. (2016) (1)
- Abstract 4936: Network signatures of survival in glioblastoma multiforme (2012) (1)
- BM-28BIOLOGICAL PATHWAYS ASSOCIATED WITH BREAST CANCER METASTASIS TO THE BRAIN (2014) (1)
- NI-07MAGNETIC RESONANCE FINGERPRINTING OF BRAIN TUMORS: INITIAL CLINICAL RESULTS (2014) (1)
- NIMG-90. TEXTURE ANALYSIS OF MR FINGERPRINTING IN ADULT BRAIN TUMORS (2017) (1)
- NI-75QUANTITATIVE TEXTURE DESCRIPTORS ON BASELINE-MRI CAN PREDICT PATIENT SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME PATIENTS. (2014) (1)
- Tumor cell phenotype and heterogeneity differences in IDH1 mutant vs wild-type gliomas (2019) (1)
- ACR Appropriateness CriteriaMetastatic Epidural Spinal Cord Compression and Recurrent Spinal Metastasis Expert Panel on Radiation Oncology-Bone Metastases: (2015) (1)
- STEM-03ATRACURIUM BESYLATE AND OTHER NEUROMUSCULAR BLOCKING AGENTS PROMOTE ASTROGLIAL DIFFERENTIATION AND DEPLETE GLIOBLASTOMA STEM CELLS. (2015) (0)
- SURG-07A MULTI-INSTITUTIONAL EXPERIENCE ON LASER THERMAL ABLATION AS TREATMENT FOR CORPUS CALLOSAL GLIOBLASOTMAS. (2015) (0)
- Impact of BRAF mutations on outcomes in metastatic melanoma with central nervous system metastases treated with immune checkpoint inhibitors. (2021) (0)
- TMOD-32. GENERATION OF GLIOBLASTOMA PATIENT DERIVED INTRACRANIAL XENOGRAFTS FOR PRECLINICAL STUDIES (2018) (0)
- SURG-21. LASER ABLATION IN STEREOTACTIC NEUROSURGERY (LAISE): A MULTI-INSTITUTIONAL RETROSPECTIVE ANALYSIS OF LITT FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMAS (GBMS) (2017) (0)
- Abstract 1279: Proteomics signature of long-term versus short-term survival in glioblastoma (2012) (0)
- Tumor and Stem Cell Biology Aptamer Identi fi cation of Brain Tumor – Initiating Cells (2013) (0)
- O6-benzylguanine (BG) and temozolomide (TMZ) therapy of glioblastoma multiforme (GBM) with infusion of autologous lentiviral transduced P140KMGMT+ hematopoietic progenitors to protect hematopoiesis: A phase I study. (2012) (0)
- 223 Procedural Safety of Stereotactic Laser Ablation (SLA) and Associated Hospital Stay: Outcome from the First Hundred Patient from LAANTERN Prospective Registry (2017) (0)
- RADI-07. GAMMA KNIFE RADIOSURGERY FOR SMALL CELL LUNG CANCER: PROGNOSTIC FACTORS INCLUDING ADDITIONAL LESIONS IDENTIFIED ON THE DAY OF RADIOSURGERY (2019) (0)
- Brain Metastasis from Sarcomas (2008) (0)
- Comparison of 18FDG-PET/MR to qualitative and semi-quantitative 18-FDG-PET/CT in differentiation of radiation necrosis from tumor recurrence (2015) (0)
- STEM-08. PLATELETS DRIVES GLIOBLASTOMA ONCOGENESIS BY ENHANCING THE GLIOMA STEM CELL PHENOTYPE (2020) (0)
- 141 Phase I Trial of Genetically Modified Hematopoietic Progenitor Cells Facilitate Bone Marrow Chemoprotection and Enabling TMZ/O6BG Dose Escalation Resulting in Improved Survival. (2016) (0)
- STEM-10. BIDIRECTIONAL INTERACTION BETWEEN TUMOR-ASSOCIATED PLATELETS AND GLIOMA STEM CELLS IN GLIOBLASTOMA MULTIFORME (2019) (0)
- Age at Diagnosis and Type of Treatment in Elderly Patients with Glioblastoma (2006) (0)
- SURG-27. STEREOTACTIC LASER ABLATION (SLA) AS TREATMENT FOR BRAIN METASTASES THAT RECUR AFTER STEREOTACTIC RADIOSURGERY: A MULTI-INSTITUTIONAL EXPERIENCE (2016) (0)
- Abstract 3318: Molecular targeting of brain tumor stem cells (2010) (0)
- Emerging Therapies for Diffuse Low Grade Glioma (2017) (0)
- Biologic pathways associated with breast cancer metastases to the brain. (2014) (0)
- Abstract 3040: Forced astroglial differentiation depletes glioblastoma stem cells (2014) (0)
- Frequency of the Metabolic Syndrome and Association with Survival in Newly Diagnosed GBM Patients: A Retrospective Review (P07.106) (2012) (0)
- Immunotherapy for malignant primary brain tumors with ICT-107, a dendritic cell vaccine (2017) (0)
- Multidisciplinary approaches to gliosarcoma: A case report and review of the literature (2022) (0)
- RNA Interference-Based Therapies Against Brain Tumors: Potential Clinical Strategies (2009) (0)
- RTHP-18. LIQUID BIOPSY DISTINGUISHES RECURRENT GBM FROM RADIATION NECROSIS IN PERIPHARAL BLOOD OF PATIENTS WITH GBM (2016) (0)
- Tumor infiltrating lymphocytes associated with brain metastasis in breast cancer. (2015) (0)
- Outcomes of melanoma patients with brain metastases receiving immune checkpoint inhibitor (ICI) therapy. (2019) (0)
- TMOD-34. A RADIOMIC SIGNATURE OF INFILTRATION IN PERITUMORAL EDEMA PREDICTS SUBSEQUENT RECURRENCE IN GLIOBLASTOMA (2019) (0)
- Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma (2018) (0)
- Treatment of brain radiation necrosis with hyperbaric oxygen: report of 6 cases (P4.218) (2015) (0)
- ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449 (2022) (0)
- SU-F-T-599: Volume-Independent Conformity Index for Stereotactic Brain Tumors. (2016) (0)
- IMMU-73. GLIOMA IN SITU VACCINATION WITH COWPEA MOSAIC VIRUS NANOPARTICLES (2018) (0)
- SURG-06. LASER ABLATION IN STEREOTACTIC NEUROSURGERY (LAISE): A MULTI-INSTITUTIONAL RETROSPECTIVE ANALYSIS OF LITT FOR BRAIN METASTASIS (2017) (0)
- Proteolytic Cleavage of Protein Tyrosine Phosphatase M Regulates Glioblastoma Cell Migration Experimental Therapeutics, Molecular Targets, and Chemical Biology (2009) (0)
- 304 Safety of Laser Ablation for Brain Tumors: Preliminary Results From the Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Registry (2018) (0)
- In-gel purified dit ags direct synthesis of highly effic ient SAGE Libraries (2002) (0)
- Abstract 2336: AD1 promotes astroglial differentiation and depletes glioblastoma stem cells (2015) (0)
- EXTH-63. A LIQUID BIOPSY TO ASSESS TUMOR RECURRENCE: PRESENCE OF MO-MDSC AND CD14+ VNN2+ CELLS IN PERIPHERAL BLOOD AS A BIOMARKER TO DISTINGUISH BRAIN METASTASIS (BM) FROM RADIATION NECROSIS AFTER STEREOTACTIC RADIOSURGERY (2017) (0)
- CMET-41. LIFETIME LUNG, BREAST, AND SKIN CANCER BRAIN METASTASES INCIDENCE: A REPRODUCIBLE SEER-MEDICARE STUDY (2018) (0)
- Underappreciated delayed late complication of adult brain irradiation: development of cerebral cavernous malformations (2007) (0)
- Stereotactic radiosurgery and resection for treatment of multiple brain metastases: a systematic review and analysis. (2022) (0)
- Multiple plasma membrane reporters discern LHFPL5 region that blocks trafficking to the plasma membrane (2023) (0)
- Longitudinal molecular trajectories of diffuse glioma in adults (2019) (0)
- Commentary: A Novel 5-Aminolevulinic Acid-Enabled Surgical Loupe System-A Consecutive Brain Tumor Series of 11 Cases. (2022) (0)
- THE P53 PATHWAY AND ANCESTRAL PROGENITORS ARE ASSOCIATED WITH TUMOR RECURRENCE IN GLIOBLASTOMA (2014) (0)
- The most significant canonical pathways represented in our validated gene list. (2014) (0)
- Disparities in the use of stereotactic radiosurgery for the treatment of lung cancer brain metastases: a SEER-Medicare study (2019) (0)
- CSIG-38. ROBO2 SIGNALING IN INVASION OF GLIOBLASTOMA (2018) (0)
- STEM-04. PLATELETS DRIVE GLIOBLASTOMA ONCOGENESIS BY ENHANCING THE GLIOMA STEM CELL PHENOTYPE (2020) (0)
- Small Animal Irradiation Using Robotic Radiosurgery and Micro-CT Images (2013) (0)
- LAB-STEM CELLS (2012) (0)
- Other complications associated with spinal stereotactic body radiation therapy (2014) (0)
- ATIM-29. NRG BN002: SAFETY DATA FROM A PHASE I STUDY OF IPILIMUMAB (IPI), NIVOLUMAB (NIVO), AND THE COMBINATION FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM) (2018) (0)
- Geographic and temporal variations in the utilization of stereotactic radiosurgery for treatment of non-small cell lung cancer brain metastases from 2010 to 2015: An analysis of the national cancer database (2020) (0)
- Targeted Therapies for Glioma Stem Cells (2016) (0)
- Targeting Telomerase With 5-Fluoro-2’-Deoxyuridine (5-FdU) In Glioma Stem Cells For The Treatment Of Glioblastoma (2020) (0)
- Targeting Telomerase With 5-Fluoro-2’-Deoxyuridine (5-FdU) In Glioma Stem Cells For The Treatment Of Glioblastoma (2020) (0)
- AI-17ROBO2-SLIT1 SIGNALING IMPLICATED IN GLIOMA INVASION (2014) (0)
- Executive Summary of the ARS Appropriate Use Criteria for Treatment of Spinal Re-irradiation (2020) (0)
- IMMU-40. ROLE OF HUMAN-β-DEFENSIN 3 IN GLIOBLASTOMA MULTIFORME (2017) (0)
- Single versus multiple session stereotactic body radiotherapy for spinal metastasis: the risk-benefit ratio (vol 11, pg 2405, 2015) (2015) (0)
- ACTR-03. A FEASIBILITY TRIAL OF THE MODIFIED ATKINS DIET AND BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA (2018) (0)
- The Evolving Genomic Landscape of Recurrent Gliomas (2015) (0)
- Biopsy-Proven Multifocal Necrotizing Leukoencephalopathy Following Systemic Methotrexate Monotherapy for CNS Metastasis of Non-Hodgkin Lymphoma (P01.107) (2013) (0)
- Is Monte Carlo Calculation Necessary in Patients With Thoracic Spinal Tumors Treated With Robotic Radiosurgery-Based Stereotactic Body Radiation Therapy (SBRT)? (2013) (0)
- Predictors of Local Failure and Leptomeningeal Disease After Adjuvant Fractionated Stereotactic Radiosurgery for Resected Brain Metastases. (2021) (0)
- Viral Insertion Safety in Patients with Glioblastoma Who Received a Novel Lentiviral MGMT-P140K Gene Therapy to Protect Bone Marrow from Chemotherapy: No Dominant Clonal Evolution Observed with Chemo-Selection (2014) (0)
- Abstract 4761: Regulation of TNFα-induced cell death of primary human brain microvessel endothelial cells by integrins (2011) (0)
- Abstract 5216: An Akt-EphA2 reciprocal regulatory loop controls tumor cell migration and invasion (2010) (0)
- Introduction to Laser Ablation Video Supplement. (2018) (0)
- Abstract 4220: Heterogeneous distribution of prognostic protein markers in glioblastoma (2018) (0)
- First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma (2018) (0)
- Abstract PD8-09: Genome-scale systems biology analyses reveal potentially targetable signaling networks in breast cancer brain metastases (2020) (0)
- Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases (2019) (0)
- Poster ViewingHypofractionated Stereotactic Radiation Therapy to the Surgical Bed for Patients With Brain Metastases Provides Effective Local Control for Bed ≥ 48 (2017) (0)
- Comparison of Near-Infrared Imaging Agents Targeting the PTPmu Tumor Biomarker. (2023) (0)
- Erratum: Brain tumor biobanking in the precision medicine era: Building a high-quality resource for translational research in neuro-oncology [Neurooncol Pract (2016)] DOI:10.1093/nop/npw029 (2017) (0)
- Abstract 129: Integrated genomic analysis of survival outliers in glioblastoma (2016) (0)
- GE-17ALTERATION OF THE p53 PATHWAY AND ANCESTRAL PROGENITORS ARE ASSOCIATED WITH TUMOR RECURRENCE IN GLIOBLASTOMA (2014) (0)
- NIMG-15. VOLUMETRIC 3D MR FINGERPRINTING OF ADULT BRAIN TUMORS: INITIAL RESULTS (2017) (0)
- NCOG-33. HEMATOLOGIC PREDICTORS OF OUTCOMES IN GLIOBLASTOMA TREATED WITH SURGERY AND CHEMORADIATION (2020) (0)
- Abstract B130: The intratumoral heterogeneity of glioblastoma suggests a pivotal role for clonal evolution. (2013) (0)
- Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma (2020) (0)
- Integration of cancer stem cell maintenance and lipid metabolism by scavenger receptors. (2014) (0)
- 151 Effect Of Pretreatment Lymphopenia On Survival In Patients With Recurrent Glioblastoma Receiving Immunotherapy (2013) (0)
- GE-03GENOMIC CHARACTERIZATION OF SURVIVAL OUTLIERS IN GLIOBLASTOMA MULTIFORME (2014) (0)
- TMOD-16. MODELING GLIOBLASTOMA THROUGH CANCER STEM CELL ORGANOIDS (2017) (0)
- Abstract 984: Alteration of the p53 pathway is associated with subclonal tumor progression in glioblastoma (2014) (0)
- GENO-05CHROMOTHRIPSIS IS A COMMON MECHANISM DRIVING GENOMIC REARRANGEMENTS IN GLIOBLASTOMA (2015) (0)
- NCMP-01. COMPARISON AND QUANTITATION OF HISTOPATHOLOGY ABNORMALITIES IN SURGICALLY RESECTED CEREBRAL RADIATION NECROSIS AS COMPARED WITH RECURRENT BRAIN TUMOR FOLLOWING RADIATION (2018) (0)
- Abstract 5192: Platelet derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity (2012) (0)
- 372 Evolving Patterns in Clinical Utilization of Stereotactic Laser Ablation (SLA): An Analysis of the Multi-center Prospective Registry LAANTERN (2017) (0)
- N 6-methyladenine DNA Modification in Glioblastoma Graphical (2018) (0)
This paper list is powered by the following services:
Other Resources About Andrew E. Sloan
What Schools Are Affiliated With Andrew E. Sloan?
Andrew E. Sloan is affiliated with the following schools:
